This alternative to an IPO called a SPAC enables small investors to invest early in an electric-truck maker, a space tourism business and more…and a lot more opportunities are on the way.
Genetic blood testing is a $6 billion market destined to grow to $50 billion.
Some major companies will never fully recover from the pandemic plunge, making them “toxic stocks” that should be shunned.
More than half-a-dozen brokerages let you buy slices of a stock for as little as a few dollars per share.
Attractive foreign stocks include companies that are helping parts of the world deal with the pandemic, defense spending, low interest rates and more.
These companies test for current or past coronavirus or for other diseases that can be detected from home tests.
The stocks this fund manager hunts for are tapping into consumer trends that have gotten a boost from the upheaval in consumer behavior and spending.
Choosing companies that boost payouts despite today’s challenges is a great strategy for the rocky environment that investors face.
Spending on space ventures is expected to triple to $1.1 trillion by 2040, providing big opportunities for long-term stock investors.
This year’s financial meltdown has put a spotlight on how damaging the wrong kind of buyback can be.
As the world adapts to COVID-19, here are stocks that stand to benefit from the shifts in business, consumer and social behavior
At a time when the dividends of many previously reliable companies are in danger, here are some stocks with rock-solid dividends.
Several trends are driving growth in the videogame industry. Here are some of the most attractive stocks that benefit.
Stocks of companies that will reinvent how their industries operate and transform the lives of their customers are a good investment opportunity.
: Rich opportunities in low-priced stocks range from a beer giant and a smartphone pioneer to a global meat exporter and a gold miner.
